118 related articles for article (PubMed ID: 38179759)
21. A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma.
Chen J; Zhang D; Ren X; Wang P
Aging (Albany NY); 2023 Oct; 15(20):11012-11032. PubMed ID: 37847171
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma.
Cheng G; Yu Y; Wang L; Pan Q
Aging (Albany NY); 2020 Apr; 12(8):7448-7464. PubMed ID: 32315986
[TBL] [Abstract][Full Text] [Related]
23. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
[TBL] [Abstract][Full Text] [Related]
24. Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma.
Cai C; Shu K; Chen W; Ding J; Guo Z; Wei Y; Zhang W
Aging (Albany NY); 2023 Jun; 15(12):5304-5338. PubMed ID: 37379129
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
26. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
27. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
28. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
32. Effect of Aberrant Long Noncoding RNA on the Prognosis of Clear Cell Renal Cell Carcinoma.
Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
Comput Math Methods Med; 2021; 2021():6533049. PubMed ID: 34512796
[TBL] [Abstract][Full Text] [Related]
33. Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma.
Zhang M; Liu YF; Gao Y; Zhao C; Chen M; Pan KH
Transl Oncol; 2023 Aug; 34():101693. PubMed ID: 37315507
[TBL] [Abstract][Full Text] [Related]
34. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract][Full Text] [Related]
35. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
36. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
37. The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma.
Ahmadi M; Najari-Hanjani P; Ghaffarnia R; Ghaderian SMH; Mousavi P; Ghafouri-Fard S
Pathol Res Pract; 2023 Nov; 251():154903. PubMed ID: 37879147
[TBL] [Abstract][Full Text] [Related]
38. Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology.
Wang Y; Yan K; Wang L; Bi J
BMC Cancer; 2021 Jun; 21(1):727. PubMed ID: 34167490
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
40. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
